| Financial Year |
March 31 2023 |
| Monetary Funds |
1,002,871,779.91 |
| Held-for-trading Financial Assets |
115,111.32 |
| Notes Receivable |
666,328,821.02 |
| Accounts Receivable |
1,007,689,415.51 |
| Advances to Suppliers |
64,095,497.00 |
| Other Receivables |
39,714,256.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
483,803,699.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
111,329,942.62 |
| Other Current Assets |
25,190,838.47 |
| Total Current Assets |
3,559,569,013.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,645,400.00 |
| Long-term Equity Investment |
99,401,472.41 |
| Investment Properties |
19,598,032.34 |
| Fixed Assetes |
877,624,456.17 |
| Under-construction Projects |
565,769,278.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
202,870,715.49 |
| R&D expenses |
-- |
| Goodwill |
5,553.33 |
| Long-Term Deferred and Prepaid Expenses |
330,636.37 |
| Deferred Income Tax Assets |
44,807,039.12 |
| Other Non-Current Assets |
79,271,495.62 |
| Sub-Total of Non-Current Assets |
2,475,012,902.14 |
| Total Assets |
6,034,581,915.81 |
| Short-Term Loans |
314,023,013.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
944,451,872.85 |
| Accounts Payable |
446,414,312.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,266,211.49 |
| Taxes Payable |
22,792,244.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,756,119.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,398,651.63 |
| Other Current Liabilities |
241,810,553.37 |
| Sub-Total of Current Liabilities |
2,097,524,034.45 |
| Long-term Loans |
321,486,166.67 |
| Bonds Payable |
734,157,471.96 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
93,197.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,106,349,333.87 |
| Total Liabilities |
3,203,873,368.32 |
| Paid-In Capital(Or Share Stock) |
430,888,395.00 |
| Capital Surplus |
956,294,212.04 |
| Surplus Reserve |
135,925,445.52 |
| LESS:Treasury Stock |
30,592,651.87 |
| Undistributed Profits |
1,202,792,517.87 |
| Minority Stockholder's Interest |
6,133,054.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,824,575,493.23 |
| Owner's Equity（Stockholder's Equity） |
2,830,708,547.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,034,581,915.81 |
